Latest stories on MNOV
MediciNova CEO provides update on results from Phase 2 trial of MN-001
The Fly56 · neutralproduct/pr
MediciNova CEO Provides Shareholder Update
Business Insider50 · neutralgeneral
MediciNova to Participate in the Maxim Growth Summit
GlobeNewswire56 · neutralgeneral
MediciNova to Participate in the Maxim Growth Summit
Business Insider55 · neutralgeneral
MediciNova Extends Office Lease, Signals Long-Term Stability
TipRanks56 · neutralgeneral
MEDICINOVA INC (MNOV) files 8-K
SEC 8-K50 · neutralgeneral
MediciNova Shares Fall After Phase 2 Tipelukast Trial Misses Primary Endpoints
InvestorsHub28 · bearishearnings
Why is MediciNova stock sliding today?
Investing.com Markets42 · neutralgeneral
MediciNova stock tumbles on mixed Phase 2 NAFLD trial data
Investing.com Markets34 · bearishproduct/pr
At a glance: stocks gapping down premarket
Seeking Alpha34 · bearishgeneral
MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001
The Fly50 · neutralgeneral
MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Business Insider56 · neutralproduct/pr
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Stocktwits News63 · neutralearnings
MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
Business Insider63 · neutralproduct/pr
MediciNova initiated with a Buy at Roth Capital
The Fly61 · neutralanalyst
Roth/MKM initiates MediciNova stock with buy on ALS drug potential
Investing.com Analyst Ratings61 · neutralanalyst
MediciNova to Participate in Two Investor Conferences in September
StockTitan55 · neutralgeneral
MediciNova to Participate in Two Investor Conferences in September
GlobeNewswire55 · neutralgeneral
MEDICINOVA INC (MNOV) files 8-K
SEC 8-K50 · neutralgeneral
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection
TipRanks50 · neutralgeneral
MEDICINOVA INC (MNOV) files 8-K
SEC 8-K50 · neutralgeneral
MediciNova CEO Provides Shareholder Update | MNOV Stock News
StockTitan59 · neutralproduct/pr
MEDICINOVA INC (MNOV) files 8-K
SEC 8-K50 · neutralgeneral